Literature DB >> 22081459

A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.

Peter J Hosein1, Michael D Craig, Martin S Tallman, Ralph V Boccia, Brian L Hamilton, Jonathan J Lewis, Izidore S Lossos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22081459     DOI： 10.1002/ajh.22232

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  8 in total

1.  A novel organic arsenic derivative MZ2 remodels metabolism and triggers mtROS-mediated apoptosis in acute myeloid leukemia.

Authors:  Guopeng Chen; Wenyan She; Chaochao Yu; Tuerxunayi Rouzi; Xinqi Li; Linlu Ma; Nan Zhang; Hongqiang Jiang; Xiaoyan Liu; Jinxian Wu; Qian Wang; Hui Shen; Fuling Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-03       Impact factor: 4.322

2.  The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.

Authors:  Dashnamoorthy Ravi; Savita Bhalla; Ronald B Gartenhaus; Jennifer Crombie; Irawati Kandela; Jaya Sharma; Andrew Mazar; Andrew M Evens
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

3.  Standardization of [F-18]FDG PET/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multicenter phase II trial.

Authors:  Hyeyeol Bae; Junichi Tsuchiya; Takehito Okamoto; Ikuko Ito; Yusuke Sonehara; Fumiko Nagahama; Kazunori Kubota; Ukihide Tateishi
Journal:  Jpn J Radiol       Date:  2018-09-24       Impact factor: 2.374

Review 4.  Glutathione S-conjugates as prodrugs to target drug-resistant tumors.

Authors:  Emma E Ramsay; Pierre J Dilda
Journal:  Front Pharmacol       Date:  2014-08-11       Impact factor: 5.810

Review 5.  Metabolism, toxicity and anticancer activities of arsenic compounds.

Authors:  Islam Khairul; Qian Qian Wang; Yu Han Jiang; Chao Wang; Hua Naranmandura
Journal:  Oncotarget       Date:  2017-04-04

Review 6.  ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammation.

Authors:  Jianlu Wei; Brendon Richbourgh; Tanghong Jia; Chuanju Liu
Journal:  Mediators Inflamm       Date:  2014-04-28       Impact factor: 4.711

Review 7.  Therapeutic options in peripheral T cell lymphoma.

Authors:  Yaping Zhang; Wei Xu; Hong Liu; Jianyong Li
Journal:  J Hematol Oncol       Date:  2016-04-12       Impact factor: 17.388

8.  Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea.

Authors:  Michinori Ogura; Won-Seog Kim; Toshiki Uchida; Naokuni Uike; Youko Suehiro; Kenichi Ishizawa; Hirokazu Nagai; Fumiko Nagahama; Yusuke Sonehara; Kensei Tobinai
Journal:  Jpn J Clin Oncol       Date:  2021-02-08       Impact factor: 3.019
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.